Computer-Aided Pathologic Diagnosis of Nasopharyngeal Carcinoma Based on Deep Learning.

Journal: The American journal of pathology
Published Date:

Abstract

The pathologic diagnosis of nasopharyngeal carcinoma (NPC) by different pathologists is often inefficient and inconsistent. We have therefore introduced a deep learning algorithm into this process and compared the performance of the model with that of three pathologists with different levels of experience to demonstrate its clinical value. In this retrospective study, a total of 1970 whole slide images of 731 cases were collected and divided into training, validation, and testing sets. Inception-v3, which is a state-of-the-art convolutional neural network, was trained to classify images into three categories: chronic nasopharyngeal inflammation, lymphoid hyperplasia, and NPC. The mean area under the curve (AUC) of the deep learning model is 0.936 based on the testing set, and its AUCs for the three image categories are 0.905, 0.972, and 0.930, respectively. In the comparison with the three pathologists, the model outperforms the junior and intermediate pathologists, and has only a slightly lower performance than the senior pathologist when considered in terms of accuracy, specificity, sensitivity, AUC, and consistency. To our knowledge, this is the first study about the application of deep learning to NPC pathologic diagnosis. In clinical practice, the deep learning model can potentially assist pathologists by providing a second opinion on their NPC diagnoses.

Authors

  • Songhui Diao
    Shenzhen Institutes of Advanced Technology, Chinese Academy of Science, Shenzhen, China; Shenzhen College of Advanced Technology, University of Chinese Academy of Sciences, Shenzhen, China.
  • Jiaxin Hou
    Shenzhen Institutes of Advanced Technology, Chinese Academy of Science, Shenzhen, China; College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China.
  • Hong Yu
    University of Massachusetts Medical School, Worcester, MA.
  • Xia Zhao
    Stony Brook University, Stony Brook, NY.
  • Yikang Sun
    Department of Pathology, Cancer Research Institute, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen Third People's Hospital, National Clinical Research Center for Infectious Diseases, Shenzhen, China.
  • Ricardo Lewis Lambo
    Shenzhen Institutes of Advanced Technology, Chinese Academy of Science, Shenzhen, China.
  • Yaoqin Xie
    Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China.
  • Lei Liu
    Department of Science and Technology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Wenjian Qin
    Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
  • Weiren Luo
    Department of Pathology, Cancer Research Institute, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen Third People's Hospital, National Clinical Research Center for Infectious Diseases, Shenzhen, China. Electronic address: binglike-01@szsy.sustech.edu.cn.